Expert Ratings for Rain Oncology
Rain Oncology (NASDAQ:RAIN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 300 points on Tuesday. Here are some big stocks recording losses in today’s session.
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session.
EF Hutton Initiates Coverage On Rain Oncology with Buy Rating, Announces Price Target of $16
EF Hutton analyst Tony Butler initiates coverage on Rain Oncology (NASDAQ:RAIN) with a Buy rating and announces Price Target of $16.
Rain Therapeutics Q3 EPS $(0.68), Inline
Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.68) per share which met the analyst consensus estimate. This is a 2.86 percent increase over losses of $(0.70) per share from the same period last year.
Rain Therapeutics Experimental Cancer Therapy Shows Encouraging Tumor Regression Activity
Rain Therapeutics Inc (NASDAQ:RAIN) announced preliminary data from Phase 2 basket trial evaluating milademetan for MDM2-amplified advanced solid tumors. “Treatment…
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers
Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
